Volume 16, Number 10—October 2010
Dispatch
Human Cases of Methicillin-Resistant Staphylococcus aureus CC398, Finland
Table 1
Cluster | Year | No. isolates | Origin | spa type | SCCmec | MLST | Antimicrobial drug resistance† | Healthcare district |
---|---|---|---|---|---|---|---|---|
1 |
2007 | 1 | Human | t011 | IV | 398 | tet, gen, tob | A |
2007 |
13 |
Horse |
t011 |
IV |
398 |
tet, gen, tob |
||
2 |
2008 |
3 |
Human |
t011 |
V |
1375 |
tet, ery, cli |
A, B |
Single |
2008 |
1 |
Human |
t2922 |
V |
398 |
tet, ery, cli |
A |
3 |
2008–09 |
5 |
Human |
t034 |
V |
398 |
tet, ery, cli (inducible) |
C |
4 | 2008–09 | 7 | Pig | t108 | V | 398 | tet, ery, cli |
*MRSA, methicillin-resistant Staphylococcus aureus; CC, clonal complex; SCCmec, staphylococcal cassette chromosome mec; MLST, multilocus sequence typing; tet, tetracycline; gen, gentamicin; tob, tobramycin; ery, erythromycin; cli, clindamycin.
†All isolates were negative for Panton-Valentine leukocidin except cluster 3.
Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.